沃森生物2025年第三季度净利润同比增长40.19%

Core Insights - Watson Bio reported a revenue of 565 million yuan for Q3 2025, representing a year-on-year decline of 20.25% [2] - The net profit attributable to shareholders for Q3 2025 was 120 million yuan, showing a year-on-year increase of 40.19% [2] - For the first three quarters of 2025, the company achieved a total revenue of 1.719 billion yuan, down 19.73% year-on-year [2] - The net profit attributable to shareholders for the first three quarters of 2025 was 163 million yuan, reflecting a year-on-year decrease of 36.24% [2]